Grade 1 2 3 4 5 Gastrointestinal Hyporexia 10 8 5 Diarrhea 14 11 3 Hematochezia/ melena 3 1 Vomiting 10 5 1 Weight loss 6 4 7 Hematologic Anemia… Click to show full abstract
Grade 1 2 3 4 5 Gastrointestinal Hyporexia 10 8 5 Diarrhea 14 11 3 Hematochezia/ melena 3 1 Vomiting 10 5 1 Weight loss 6 4 7 Hematologic Anemia 11 1 1 Neutropenia 4 1 1 1 Thrombocytopenia 6 3 2 1 Cutaneous/Pulmonary Dermatopathy 9 5 1 Pulmonary fibrosis 1 Pneumonia 1 Evan's syndrome suspected to be unrelated to rabacfosadine/L-asparaginase. Adverse events resulting in withdrawal from study in select cases. Adverse events resulting in dose reduction or dose delay in select cases. Received: 8 April 2020 Accepted: 8 April 2020 DOI: 10.1111/jvim.15786
               
Click one of the above tabs to view related content.